201 related articles for article (PubMed ID: 10940145)
1. Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.
Connelly MT; Richardson M; Platt R
J Gen Intern Med; 2000 Aug; 15(8):542-50. PubMed ID: 10940145
[TBL] [Abstract][Full Text] [Related]
2. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
[TBL] [Abstract][Full Text] [Related]
5. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.
Rutter CM; Mandelson MT; Laya MB; Seger DJ; Taplin S
JAMA; 2001 Jan; 285(2):171-6. PubMed ID: 11176809
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
7. Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion.
McNagny SE; Jacobson TA
Arch Intern Med; 1997 Jun; 157(12):1337-42. PubMed ID: 9201008
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
12. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
Lukes A
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward hormone replacement therapy in the new millennium: university physicians' and patients' perspectives.
Ismail HM; Aleveritis E; Guha B; Olive K; Sloan S
J Investig Med; 2005 Sep; 53(6):305-11. PubMed ID: 16207467
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy for cognitive function in postmenopausal women.
Lethaby A; Hogervorst E; Richards M; Yesufu A; Yaffe K
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003122. PubMed ID: 18254016
[TBL] [Abstract][Full Text] [Related]
17. Low use of long-term hormone replacement therapy in Denmark.
Olesen C; Steffensen FH; Sørensen HT; Nielsen GL; Olsen J; Bergman U
Br J Clin Pharmacol; 1999 Mar; 47(3):323-8. PubMed ID: 10215757
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.
Amigoni S; Morelli P; Chatenoud L; Parazzini F
Climacteric; 2000 Mar; 3(1):25-32. PubMed ID: 11910606
[TBL] [Abstract][Full Text] [Related]
19. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
20. Duration of hormonal replacement therapy in general practice; a follow-up study.
Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
Maturitas; 1998 Jun; 29(2):125-31. PubMed ID: 9651901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
